English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 934433      Online Users : 561
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Shan, YS" 

    Return to Browse by Author

    Showing 123 items.

    Collection Date Title Relation Bitstream
    [其他] 期刊論文 2020-01 DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination -
    [其他] 期刊論文 2016-07 KIT exon 11 codons 557-558 deletion mutation promotes liver metastasis through the CXCL12/CXCR4 axis in gastrointestinal stromal tumors -
    [其他] 期刊論文 2022-08-19 Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer -
    [姜乃榕] 會議論文/會議摘要 2023-06 Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors -
    [姜乃榕] 會議論文/會議摘要 2022-10 An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis -
    [姜乃榕] 會議論文/會議摘要 2022-06 Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma -
    [姜乃榕] 會議論文/會議摘要 2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer -
    [姜乃榕] 會議論文/會議摘要 2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma -
    [姜乃榕] 會議論文/會議摘要 2020-11 An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents -
    [姜乃榕] 會議論文/會議摘要 2019-02 Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma -
    [姜乃榕] 會議論文/會議摘要 2018-10 Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study -
    [姜乃榕] 會議論文/會議摘要 2017-02 A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer -
    [姜乃榕] 會議論文/會議摘要 2016-02 Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy -
    [姜乃榕] 會議論文/會議摘要 2016-02 Phase I trial of biweekly S-1, leucovorin, oxaliplatin, and gemcitabine (the SLOG regimen) in metastatic pancreatic adenocarcinoma (mPDAC) -
    [姜乃榕] 期刊論文 2022-12-15 An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes -
    [姜乃榕] 期刊論文 2022-10 The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma -
    [姜乃榕] 期刊論文 2022-09-15 Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin -
    [姜乃榕] 期刊論文 2022-09 A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study -
    [姜乃榕] 期刊論文 2022-06-26 The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer -
    [姜乃榕] 期刊論文 2022-06-16 Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study -
    [姜乃榕] 期刊論文 2022-06 Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin -
    [姜乃榕] 期刊論文 2022-04-15 The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan -
    [姜乃榕] 期刊論文 2021-11-01 Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma -
    [姜乃榕] 期刊論文 2020-11-01 Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients -
    [姜乃榕] 期刊論文 2020-05 Exploring Circulating Tumor Cells in cholangiocarcinoma using a novel glycosaminoglycan probe on a microfluidic platform -
    [姜乃榕] 期刊論文 2017-09 Screening of peptide specific to cholangiocarcinoma cancer cells using an integrated microfluidic system and phage display technology -
    [姜乃榕] 期刊論文 2017-07-01 Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform -
    [姜乃榕] 期刊論文 2017-06-26 A microfluidic chip for detecting cholangiocarcinoma cells in human bile -
    [常慧如] 會議論文/會議摘要 2018-10 Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study -
    [張書銘] 會議論文/會議摘要 2018-12 The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan -
    [張書銘] 會議論文/會議摘要 2018-01 Environmental tobacco smoke and risk of pancreatic cancer among never smokers -
    [張書銘] 會議論文/會議摘要 2015-08 The association between periodontal disease and pancreatic cancer -
    [張書銘] 期刊論文 2021-07-15 No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol -
    [張書銘] 期刊論文 2020-05-26 Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan -
    [張書銘] 期刊論文 2015-06 Comprehensive analysis of the incidence and survival patterns of lung cancer by histologies, including rare subtypes, in the era of molecular medicine and targeted therapy: A nation-wide cancer registry-based study from Taiwan -
    [楊奕馨] 期刊論文 2021-11-30 Survival outcomes of management in metastatic gastric adenocarcinoma patients -
    [洪文俊] 會議論文/會議摘要 2018-12 c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation -
    [洪文俊] 會議論文/會議摘要 2016-11 Role of epigenetic regulator EHMT2 in the regulation of gemcitabine resistance in pancreatic cancer -
    [洪文俊] 期刊論文 2019-07 Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer -
    [洪文俊] 期刊論文 2019-01 Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer -
    [洪文俊] 期刊論文 2018-12-20 Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression -
    [洪文俊] 期刊論文 2016-09 The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer -
    [蔡坤志] 期刊論文 2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer -
    [蔡坤志] 期刊論文 2021-05 A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 May;24(3):624-639.] -
    [蔡坤志] 期刊論文 2019-12 The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis -
    [蔡坤志] 期刊論文 2016-12 Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells -
    [蔡坤志] 期刊論文 2013-11 A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression -
    [蔡坤志] 期刊論文 2012-08 Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma -
    [蔡慧珍] 會議論文/會議摘要 2018-01 The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors -
    [蔡慧珍] 期刊論文 2024-07-11 Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study -
    [蔡慧珍] 期刊論文 2022-11-06 PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation -
    [蔡慧珍] 期刊論文 2021-04-12 An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan -
    [蔡慧珍] 期刊論文 2021-01 c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation -
    [蔡慧珍] 期刊論文 2018-11 The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan -
    [蕭金福] 會議論文/會議摘要 2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial -
    [蕭金福] 會議論文/會議摘要 2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial -
    [蕭金福] 期刊論文 2021-05 High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial -
    [蕭金福] 期刊論文 2020-05 An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas -
    [蕭金福] 期刊論文 2018-07 The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients -
    [蕭金福] 期刊論文 2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial -
    [蘇勇曄] 會議論文/會議摘要 2023-11 Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis -
    [蘇勇曄] 期刊論文 2022-11-15 The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma -
    [蘇勇曄] 期刊論文 2021-11-20 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study -
    [邱燕楓] 期刊論文 2023-09 Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized study -
    [鄒小蕙] 會議論文/會議摘要 2018-11 TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer -
    [陳立宗] 會議論文/會議摘要 2022-07 Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience -
    [陳立宗] 會議論文/會議摘要 2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer -
    [陳立宗] 會議論文/會議摘要 2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma -
    [陳立宗] 會議論文/會議摘要 2017-11 Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI65-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2017-11 CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) � 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2017-09 Mutant KIT translocates into the nucleus and induces NFKBIB expression that leads to KIT expression in imatinib-resistant gastrointestinal stromal tumors -
    [陳立宗] 會議論文/會議摘要 2017-06-26 Subgroup analysis by prior non-liposomal irinotecan therapy in NAPOLI-1: A phase 3 study of nal-IRI +/- 5-fluorouracil/leucovorin in patients with metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2017-06-26 CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) +/- 5-fluorouracil and leucovorin (5FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2016-12 Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study -
    [陳立宗] 會議論文/會議摘要 2016-12 Sequential use of everolimus and sunitinib in treating WHO grade 1 and 2 pancreatic neuroendocrine tumors-retrospective multi-center study in Taiwan -
    [陳立宗] 會議論文/會議摘要 2016-10 Final results of NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2016-10 Time course of selected treatment emergent adverse events (TEAEs) in NAPOLI-1: A phase 3 study of nal-IRI (MM-398) +/- 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based ther -
    [陳立宗] 會議論文/會議摘要 2016-05 Updated overall survival (OS) analysis of NAPOLI-1: Phase 3 study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), vs 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine -
    [陳立宗] 會議論文/會議摘要 2016-02 Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2016-02 Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2015-09 The safety and efficacy of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan -
    [陳立宗] 會議論文/會議摘要 2015-01 Expanded analyses of napoli-1: Phase 3 study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin, versus 5-fluorouracil and leucovorin, in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy -
    [陳立宗] 會議論文/會議摘要 2014-01 Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial -
    [陳立宗] 會議論文/會議摘要 2013-05 KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial -
    [陳立宗] 期刊論文 2024-10 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study -
    [陳立宗] 期刊論文 2024-05 Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer -
    [陳立宗] 期刊論文 2024-02-13 Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan -
    [陳立宗] 期刊論文 2023-09-01 The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study -
    [陳立宗] 期刊論文 2023-08-15 Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination -
    [陳立宗] 期刊論文 2023-08 The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study -
    [陳立宗] 期刊論文 2023-02-05 Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer -
    [陳立宗] 期刊論文 2023-02 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan -
    [陳立宗] 期刊論文 2022-10 Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study -
    [陳立宗] 期刊論文 2022-06-22 Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study -
    [陳立宗] 期刊論文 2022-05-15 Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience -
    [陳立宗] 期刊論文 2022-04 A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study -
    [陳立宗] 期刊論文 2022-02-24 Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway -
    [陳立宗] 期刊論文 2021-11-12 The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience -
    [陳立宗] 期刊論文 2021-01-13 Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials -
    [陳立宗] 期刊論文 2020-11-13 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] -
    [陳立宗] 期刊論文 2020-10 Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study -
    [陳立宗] 期刊論文 2020-05-04 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort -
    [陳立宗] 期刊論文 2020-02 Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study -
    [陳立宗] 期刊論文 2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study -
    [陳立宗] 期刊論文 2019-10 The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan -
    [陳立宗] 期刊論文 2019-09 Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors -
    [陳立宗] 期刊論文 2019-09 Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8 -
    [陳立宗] 期刊論文 2019-05-20 Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer -
    [陳立宗] 期刊論文 2018-11-07 Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial -
    [陳立宗] 期刊論文 2018-03 Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy -
    [陳立宗] 期刊論文 2017-10-09 Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors -
    [陳立宗] 期刊論文 2017-09-16 The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors -
    [陳立宗] 期刊論文 2016-12 The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan -
    [陳立宗] 期刊論文 2016-07 Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer -
    [陳立宗] 期刊論文 2016-05-03 Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer -
    [陳立宗] 期刊論文 2016-02 Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial -
    [陳立宗] 期刊論文 2016-01 Investigating the association between periodontal disease and risk of pancreatic cancer -
    [陳立宗] 期刊論文 2015-10 Epigenetic regulation in the carcinogenesis of cholangiocarcinoma -
    [陳立宗] 期刊論文 2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer -
    [陳立宗] 期刊論文 2013-11 Management of gastric cancer in Asia: Resource-stratified guidelines -
    [陳立宗] 期刊論文 2013-08 A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer -
    [陳立宗] 期刊論文 2013-06-20 Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations -
    [陳立宗] 期刊論文 2011-12 Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study -

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback